We next compared 1, 25-D3 and IGFBP-3 treatment on MAPK and Akt activation in parental and resistant cells since it is well documented that IGF-I/MAPK and IGF-I/Akt signalling plays a crucial role in proliferation and survival of breast cancer cells. This evidence concerns the gene IGFBP3 and breast carcinoma.